Becton Dickinson and Co. (NYSE:BDX) on Monday reported first-quarter 2026 adjusted earnings of $2.91 per share, beating the consensus of $2.81.
The company reported sales of $5.25 billion, slightly above the consensus of $5.15 billion.
Guidance
The company is providing guidance for fiscal year 2026 for New BD, reflecting the separation of its Biosciences and Diagnostic Solutions businesses and the combination with Waters Corporation (NYSE:WAT).
Becton Dickinson lowers fiscal 2026 adjusted earnings guidance from $14.75-$15.05 per share to $12.35-$12.65 per share compared to the consensus of $14.72.
RBC Cuts Price Target
RBC Capital Markets lowered its price forecast for Becton Dickinson from $210 to $172, citing “We see FY26 as a transition year.”
RBC said that the updated price forecast reflects the Waters deal dynamics. The analyst models organic revenue growth of 2.5% …